The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Holding patents (8999996, 9079865, 9714226, PCT/US12/048319, and I574957) on hydrazide-containing nuclear transport modulators and uses, and holding pending patents (PCT/US12/048319, 499/2012, PI20102724, and 2012000928) on hydrazide-containing nuclear tr
Updated overall survival of eltanexor for the treatment of patients with hypomethylating agent refractory myelodysplastic syndrome.
 
Sangmin Lee
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Helsinn Healthcare; Innate Pharma; Jazz Pharmaceuticals; PIN therapeutics; Roche
Research Funding - AstraZeneca; FORMA Therapeutics; Janssen; Karyopharm Therapeutics; LAM Therapeutics; Stemline Therapeutics
 
Sanjay Mohan
Research Funding - Astex Pharmaceuticals; Incyte
 
Jessica Knupp
Employment - Celgene; Karyopharm Therapeutics
Stock and Other Ownership Interests - Celgene; Karyopharm Therapeutics
 
Kamal Chamoun
No Relationships to Disclose
 
Xiang BAI
Employment - Biogen (I); Karyopharm Therapeutics
Stock and Other Ownership Interests - Biogen (I); Karyopharm Therapeutics
Research Funding - Biogen (I); Karyopharm Therapeutics
Travel, Accommodations, Expenses - BioPharm (I); Karyopharm Therapeutics
 
Xiwen Ma
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Jatin J. Shah
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Michael Kauffman
No Relationships to Disclose
 
Sharon Shacham
No Relationships to Disclose
 
Bhavana Bhatnagar
Honoraria - Astellas Pharma; Cell Therapeutics; Kite, a Gilead Company; novartis; Pfizer
Research Funding - Cell Therapeutics; Karyopharm Therapeutics; Sumitomo Dainippon Pharma Oncology